Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-05 4:38 pm Sale |
2021-02-02 | 13G | Verona Pharma plc VRNA |
Novo Holdings A/S | 12,893,250 3.100% |
-9,746,417 (-43.05%) |
Filing History |
| 2021-02-01 4:31 pm Sale |
2021-01-28 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 2,194,379 9.400% |
-375,000 (-14.59%) |
Filing History |
| 2020-12-30 1:36 pm Sale |
2020-12-30 | 13G | SeaSpine Holdings Corporation SPNE |
Novo Holdings A/S | 1,346,487 4.800% |
-311,550 (-18.79%) |
Filing History |
| 2020-12-18 4:31 pm Unchanged |
2020-12-15 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 2,445,147 8.400% |
0 (Unchanged) |
Filing History |
| 2020-11-05 4:38 pm Purchase |
2020-10-28 | 13D | Galecto, Inc. GLTO |
Novo Holdings A/S | 99,912 10.200% |
99,912 (New Position) |
Filing History |
| 2020-10-22 4:31 pm Purchase |
2020-10-15 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 104,583 7.700% |
104,583 (New Position) |
Filing History |
| 2020-10-16 4:48 pm Purchase |
2020-10-08 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 4,989,336 21.500% |
4,989,336 (New Position) |
Filing History |
| 2020-10-05 4:47 pm Sale |
2020-09-30 | 13D | Verona Pharma plc VRNA |
Novo Holdings A/S | 22,639,667 5.400% |
-408,832 (-1.77%) |
Filing History |
| 2020-10-05 4:45 pm Unchanged |
2020-09-30 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 2,569,379 11.000% |
0 (Unchanged) |
Filing History |
| 2020-09-04 4:30 pm Sale |
2020-08-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Novo Holdings A/S | 3,754,973 6.600% |
-654,830 (-14.85%) |
Filing History |
| 2020-08-25 4:30 pm Purchase |
2020-08-18 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Novo Holdings A/S | 4,409,803 6.900% |
4,409,803 (New Position) |
Filing History |
| 2020-08-14 4:31 pm Purchase |
2020-08-11 | 13G | Freeline Therapeutics Holdings plc FRLN |
Novo Holdings A/S | 157,415 6.800% |
157,415 (New Position) |
Filing History |
| 2020-08-13 4:47 pm Purchase |
2020-08-11 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 2,170,100 10.100% |
2,170,100 (New Position) |
Filing History |
| 2020-08-11 4:30 pm Sale |
2020-08-06 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Novo Holdings A/S | 1,173,896 4.300% |
-1,007,947 (-46.20%) |
Filing History |
| 2020-07-29 4:42 pm Purchase |
2020-07-28 | 13D | Inozyme Pharma, Inc. INZY |
Novo Holdings A/S | 2,569,379 11.500% |
2,569,379 (New Position) |
Filing History |
| 2020-07-24 4:30 pm Purchase |
2020-07-22 | 13D | Verona Pharma plc VRNA |
Novo Holdings A/S | 23,048,499 5.500% |
8,888,888 (+62.78%) |
Filing History |
| 2020-07-16 4:35 pm Purchase |
2020-07-14 | 13D | Nkarta, Inc. NKTX |
Novo Holdings A/S | 2,793,865 8.590% |
2,793,865 (New Position) |
Filing History |
| 2020-07-09 4:29 pm Sale |
2020-07-07 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
Novo Holdings A/S | 1,389,498 4.970% |
-1,538,062 (-52.54%) |
Filing History |
| 2020-06-16 1:54 pm Unchanged |
2020-06-11 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Novo Holdings A/S | 2,181,843 7.990% |
0 (Unchanged) |
Filing History |